Xingliang Dai

Engages in the basic and clinical research of glioma, with a focus on the comprehensive treatment of brain glioma, including surgery, radiotherapy, chemotherapy, and targeted therapy.Has presided over 2 projects funded by the National Natural Science Foundation of China (NSFC), 1 project of the "Outstanding Young Scientists Fund" of the province, and more than 10 scientific research projects at the provincial level, such as those supported by the Provincial Natural Science Foundation, Provincial Health Commission, and Provincial Department of Education. Has published over 100 academic papers, including more than 30 SCI-indexed papers in the past 5 years, with a total impact factor exceeding 280. The H-index is 28 (based on Google Scholar).Serves concurrently as Associate Editor, Editorial Board Member, or Young Editorial Board Member for more than 10 Chinese and English journals, and acts as a peer reviewer for over 40 journals. Has participated in the compilation of one academic monograph. Holds 18 authorized national invention patents.